| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910458493503321 |
|
|
Autore |
Thrall Grant Ian |
|
|
Titolo |
Business geography and new real estate market analysis [[electronic resource] /] / Grant Ian Thrall |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Oxford ; ; New York, : Oxford University Press, 2002 |
|
|
|
|
|
|
|
ISBN |
|
0-19-756033-4 |
1-280-52628-9 |
0-19-536039-7 |
1-4294-0010-2 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (274 p.) |
|
|
|
|
|
|
Collana |
|
Spatial information systems |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Real estate investment - Evaluation |
Commercial geography |
Electronic books. |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Previously issued in print: 2002. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references (p. 241-256) and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Machine generated contents note: Part I OVERVIEW, THEORY, AND METHODS -- 1: Introduction, 3 -- 2: Understanding Real Estate Markets and Submarkets, 19 -- 3: Unifying Urban Land Use and Land Value Theories, 60 -- 4: Conducting Real Estate Market Analysis, 78 -- Part II APPLICATIONS TO REAL ESTATE PRODUCT TYPES -- 5: Housing and Residential Communities, 107 -- 6: Office and Industrial, 131 -- 7: Retail, 165 -- 8: Hotel and Motel, 199 -- 9: Mixed Use, 216 -- 10: Getting Started, 225. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
This work focuses on integrating land-use location science with the technology of geographic information systems (GIS). The text describes the principles of location decision and the means for applying them in orer to improve the real estate decision. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910298294303321 |
|
|
Titolo |
The Future of HIV-1 Therapeutics : Resistance Is Futile? / / edited by Bruce E. Torbett, David S. Goodsell, Douglas D. Richman |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2015 |
|
|
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Edizione |
[1st ed. 2015.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (257 p.) |
|
|
|
|
|
|
Collana |
|
Current Topics in Microbiology and Immunology, , 0070-217X ; ; 389 |
|
|
|
|
|
|
Disciplina |
|
610 |
616.9 |
616.9041 |
616.9101 |
|
|
|
|
|
|
|
|
Soggetti |
|
Drug resistance |
Virology |
Infectious diseases |
Drug Resistance |
Infectious Diseases |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
HIV Therapy Looking Towards the Future -- Computational challenges of structure-based approaches applied to HIV -- Nucleocapsid Protein: A Desirable Target For Future Therapies Against HIV-1 -- HIV-1 integrase multimerization as a therapeutic target -- Targeting HIV transcription: The quest for a functional cure -- Targeting the HIV RNA Genome: High-Hanging Fruit Only Needs a Longer Ladder -- HIV-1 Gag: An Emerging Target for Antiretroviral Therapy -- The Triple Threat of HIV-1 Protease Inhibitors -- Illustrations of the HIV Life Cycle. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
This volume thoroughly covers HIV-1 antiretrovirals currently in clinical use, together with their advantages and limitations. HIV-1 inhibitor resistance is discussed in detail, and critical assessments as to what will be required of future antiretrovirals in order to halt viral replication, reduce viral resistance, and alter the state of viral latency are presented. Experts at the forefront of HIV-1 research provide overviews |
|
|
|
|
|
|
|
|
|
|
of approaches from the fields of virology, chemical biology and structural biology for obtaining small molecule inhibitors that target viral regulatory and structural components at multiple points in the viral lifecycle. The individual chapters will appeal to scientists and clinicians alike. |
|
|
|
|
|
| |